Universal antibody targeting the highly conserved fusion peptide provides cross-protection in mice.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
30 11 2022
Historique:
pubmed: 21 6 2022
medline: 2 11 2022
entrez: 20 6 2022
Statut: ppublish

Résumé

Influenza is a major public health concern causing millions of hospitalizations every year. The current vaccines need annual updating based on prediction of likely strains in the upcoming season. However, mismatches between vaccines and the actual circulating viruses can occur, reducing vaccine effectiveness significantly because of the remarkably high rate of mutation in the viral glycoprotein, hemagglutinin (HA). Clearly, it would be of great interest to determine the potential role of universally conserved epitopes in inducing protective immunity. Here, an antibody against the 14-aa fusion peptide sequence at the The fusion peptide is the only universally conserved epitope in both IAV and IBVMono-specific universal antibody induces strong ADCC against human and avian IAVMono-specific universal antibody induces strong ADCC against IBV from both genetic lineages of IBVThe antibody has bi-functional effector functions against several influenza viruses.

Autres résumés

Type: plain-language-summary (eng)
The fusion peptide is the only universally conserved epitope in both IAV and IBVMono-specific universal antibody induces strong ADCC against human and avian IAVMono-specific universal antibody induces strong ADCC against IBV from both genetic lineages of IBVThe antibody has bi-functional effector functions against several influenza viruses.

Identifiants

pubmed: 35724343
doi: 10.1080/21645515.2022.2083428
pmc: PMC9621047
doi:

Substances chimiques

Hemagglutinin Glycoproteins, Influenza Virus 0
Antibodies, Viral 0
Influenza Vaccines 0
Peptides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2083428

Références

Vaccine. 2005 Nov 16;23(46-47):5404-10
pubmed: 16011865
Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17736-41
pubmed: 19004788
Biomed Res Int. 2015;2015:414637
pubmed: 25785268
Nat Rev Immunol. 2019 Jun;19(6):383-397
pubmed: 30837674
J Virol. 2012 Nov;86(21):11725-34
pubmed: 22915797
JCI Insight. 2017 Jul 6;2(13):
pubmed: 28679958
Emerg Infect Dis. 2006 Apr;12(4):569-74
pubmed: 16704803
mBio. 2014 Mar 04;5(2):e00031-14
pubmed: 24595369
Sci Rep. 2018 Jul 11;8(1):10432
pubmed: 29992986
PLoS Pathog. 2013 Feb;9(2):e1003176
pubmed: 23408893
Sci Transl Med. 2021 Jun 2;13(596):
pubmed: 34078743
Science. 2020 Jun 19;368(6497):1335-1340
pubmed: 32554590
Cell Rep. 2015 Dec 29;13(12):2842-50
pubmed: 26711348
J Immunol. 2013 Feb 15;190(4):1837-48
pubmed: 23319732
Emerg Infect Dis. 2006 Jan;12(1):9-14
pubmed: 16494710
Cell Host Microbe. 2017 Jun 14;21(6):742-753.e8
pubmed: 28618270
J Virol Methods. 2012 Oct;185(1):82-8
pubmed: 22728276
Curr Opin Biotechnol. 2007 Dec;18(6):529-36
pubmed: 18083548
Nature. 2022 Feb;602(7896):314-320
pubmed: 34942633
mBio. 2021 Feb 16;12(1):
pubmed: 33593972
Curr Opin Virol. 2015 Apr;11:113-21
pubmed: 25846699
Mol Ther. 2022 May 4;30(5):2024-2047
pubmed: 34999208
Vaccine. 2008 Nov 11;26(48):6068-76
pubmed: 19007587
Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1356-61
pubmed: 14745020
J Biol Chem. 2010 Sep 10;285(37):28411-7
pubmed: 20538599
Biochem Biophys Res Commun. 2010 Dec 10;403(2):247-51
pubmed: 21078301
iScience. 2021 Oct 21;24(11):103328
pubmed: 34805790
Front Immunol. 2019 Jun 25;10:1457
pubmed: 31316510
Vaccine. 2003 Jul 4;21(23):3212-8
pubmed: 12804850
J Clin Invest. 2015 Jul 1;125(7):2631-45
pubmed: 26011643
Science. 2012 Sep 14;337(6100):1343-8
pubmed: 22878502
Science. 2009 Apr 10;324(5924):246-51
pubmed: 19251591
Hum Vaccin Immunother. 2016 Apr 2;12(4):993-1002
pubmed: 26890005
Front Immunol. 2020 Aug 07;11:1744
pubmed: 32849622
Clin Microbiol Infect. 2017 Apr;23(4):222-228
pubmed: 28216325
Influenza Other Respir Viruses. 2018 May;12(3):383-411
pubmed: 29127742
Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9654-8
pubmed: 10920197
J Infect Dis. 2013 Oct 1;208(7):1051-61
pubmed: 23812238
Clin Infect Dis. 2014 Dec 1;59(11):1519-24
pubmed: 25139969
Cell Rep. 2022 Feb 8;38(6):110337
pubmed: 35139373
Science. 2011 Aug 12;333(6044):843-50
pubmed: 21737702
Int J Mol Sci. 2020 Oct 27;21(21):
pubmed: 33121109
Cell Host Microbe. 2016 Jun 8;19(6):800-13
pubmed: 27281570
Nat Med. 2014 Feb;20(2):143-51
pubmed: 24412922
Nat Struct Mol Biol. 2009 Mar;16(3):265-73
pubmed: 19234466
Vaccine. 2008 Sep 12;26 Suppl 4:D49-53
pubmed: 19230160
Curr Opin Immunol. 2018 Aug;53:45-50
pubmed: 29677684
Future Microbiol. 2016;11(1):119-35
pubmed: 26684590
Curr Opin Virol. 2013 Oct;3(5):521-30
pubmed: 23978327
Elife. 2014 Jul 08;3:
pubmed: 25006036
Arch Virol. 1991;116(1-4):285-92
pubmed: 1705790
J Virol. 2013 May;87(10):5512-22
pubmed: 23468501
Virology. 1990 Mar;175(1):59-68
pubmed: 2309452
Science. 2011 Aug 12;333(6044):850-6
pubmed: 21798894
PLoS Pathog. 2013;9(10):e1003657
pubmed: 24130481
J Clin Microbiol. 2014 May;52(5):1672-7
pubmed: 24622097
Science. 1998 Jan 16;279(5349):393-6
pubmed: 9430591
Microbes Infect. 2006 Feb;8(2):511-9
pubmed: 16300986
J Clin Invest. 2016 Feb;126(2):605-10
pubmed: 26731473
Arch Virol. 1987;97(3-4):251-65
pubmed: 3322235
J Virol. 2014 Nov;88(22):13418-28
pubmed: 25210172
Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S60-8
pubmed: 21342901
Nat Protoc. 2010 Jan;5(1):14-9
pubmed: 20010723
J Clin Invest. 2010 May;120(5):1663-73
pubmed: 20389023
J Clin Microbiol. 1997 May;35(5):1196-8
pubmed: 9114406
Microbiol Rev. 1992 Mar;56(1):152-79
pubmed: 1579108
Nat Commun. 2014 Apr 10;5:3614
pubmed: 24717798
Sci Transl Med. 2015 Dec 2;7(316):316ra192
pubmed: 26631631
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):445-50
pubmed: 24335589
J Infect Dis. 2006 Jan 1;193(1):49-53
pubmed: 16323131
PLoS Pathog. 2017 Mar 13;13(3):e1006271
pubmed: 28288189
Future Microbiol. 2015;10(9):1447-65
pubmed: 26357957
Acta Virol. 1987 Sep;31(5):374-86
pubmed: 2891276
Viruses. 2020 Mar 01;12(3):
pubmed: 32121563
Eur J Clin Microbiol Infect Dis. 2004 Jan;23(1):1-6
pubmed: 14663646
J Antimicrob Chemother. 1999 Nov;44 Suppl B:3-9
pubmed: 10877456

Auteurs

Abenaya Muralidharan (A)

Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA.

Caroline Gravel (C)

Centre for Biologics Evaluation, Biologic and Radiopharmaceutical Drugs Directorate, HPFB, Health Canada and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Ottawa, Canada.

Greg Harris (G)

Human Health Therapeutics (HHT) Research Center, National Research Council of Canada, Ottawa, Canada.

Anwar M Hashem (AM)

Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.

Wanyue Zhang (W)

Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
Centre for Biologics Evaluation, Biologic and Radiopharmaceutical Drugs Directorate, HPFB, Health Canada and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Ottawa, Canada.

David Safronetz (D)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.

Gary Van Domselaar (G)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.

Florian Krammer (F)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA.

Simon Sauve (S)

Centre for Biologics Evaluation, Biologic and Radiopharmaceutical Drugs Directorate, HPFB, Health Canada and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Ottawa, Canada.

Michael Rosu-Myles (M)

Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
Centre for Biologics Evaluation, Biologic and Radiopharmaceutical Drugs Directorate, HPFB, Health Canada and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Ottawa, Canada.

Lisheng Wang (L)

Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Canada.

Wangxue Chen (W)

Human Health Therapeutics (HHT) Research Center, National Research Council of Canada, Ottawa, Canada.

Xuguang Li (X)

Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
Centre for Biologics Evaluation, Biologic and Radiopharmaceutical Drugs Directorate, HPFB, Health Canada and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Ottawa, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH